PTEN p.Arg130Arg
Variant summary
The NM_000314.8(PTEN):c.388C>A (p.Arg130Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant position is a cancer hotspot (cancerhotspots.org): 239 samples carry this exact amino acid change out of 1912 samples with a variant at this residue.
Frequency
Consequence
NM_000314.8 synonymous
Scores
Clinical Significance
Conservation
Publications
- Cowden syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Lhermitte-Duclos diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- PTEN hamartoma tumor syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- macrocephaly-autism syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp
- renal cell carcinomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- leiomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- activated PI3K-delta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Bannayan-Riley-Ruvalcaba syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Proteus-like syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- glioma susceptibility 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_benign. The variant received -4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.000104 by highest known P/LP ClinVar AF 0.000104) — PM2 moderate. | ||
| BP4Computational evidence suggests no impact | Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Supporting). | ||
| BP6Reputable source reports benign | ClinVar 2-star benign — strong (BP6); ClinVar germline classification: Benign/Likely Benign, 2 star(s). | ||
| BP7Synonymous variant, no splicing impact | Synonymous variant at non-conserved position with no predicted splicing impact (BP7); Synonymous at non-conserved position, no splicing concern — benign (BP7). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PTEN | MANE Select | c.388C>A p.Arg130Arg | synonymous | Exon 5 of 9 | Prot: NP_000305.3 | |
PTEN | c.907C>A p.Arg303Arg | synonymous | Exon 6 of 10 | Prot: NP_001291646.4 | ||
PTEN | c.-363C>A | 5_prime_UTR | Exon 4 of 9 | Prot: NP_001291647.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
PTEN | TSL:1MANE Select | c.388C>A p.Arg130Arg | synonymous | Exon 5 of 9 | Prot: ENSP00000361021.3 UniProt: | |
PTEN | c.907C>A p.Arg303Arg | synonymous | Exon 6 of 10 | Prot: ENSP00000509861.1 UniProt: | ||
PTEN | c.388C>A p.Arg130Arg | synonymous | Exon 5 of 10 | Prot: ENSP00000514759.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome Warning | AF: 0.00000137 | AC:2 | Hom:0 | AN:1461670 | Cov:31 |
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 23 | |
BayesDel_noAF | Benign | -0.16 | |
CADD | Benign | 14 | |
DANN | Benign | 0.73 | |
GPN-Star LLR | N/A | -6.5 | |
GPN-Star score | N/A | 6.5 | |
PhyloP100 | Uncertain | 5.6 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
MaveDB functional evidence
- Gene
- PTEN
- Assay type
- Cell fitness
- Mechanism
- Catalytic and Lipid phosphatase activity
- Model system
- Yeast (Saccharomyces cerevisiae)
- Score
- · p.= (assay numbering)